コバスTaqMan HCV「オート」によるC型慢性肝炎抗ウイルス療法時のウイルス動態と効果予測

O Lo Iacono, G Venezia, S Petta, C Mineo, S De Lisi, V Di Marco, V Rodolico, Mc Amato, D Ferraro, C Giordano, PL Almasio, A Craxí, None, The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. ,vol. 25, pp. 1181- 1191 ,(2007) , 10.1111/J.1365-2036.2007.03309.X

Y.-H. YEN, C.-H. HUNG, T.-H. HU, C.-H. CHEN, C.-M. WU, J.-H. WANG, S.-N. LU, C.-M. LEE, Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209-2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin. Alimentary Pharmacology & Therapeutics. ,vol. 27, pp. 72- 79 ,(2007) , 10.1111/J.1365-2036.2007.03560.X

K. H. TANG, E. HERRMANN, I. PACHIADAKIS, E. PAULON, N. TATMAN, S. ZEUZEM, N. V. NAOUMOV, Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin. Alimentary Pharmacology & Therapeutics. ,vol. 27, pp. 810- 819 ,(2008) , 10.1111/J.1365-2036.2008.03628.X

Massimo Pilli, Alessandro Zerbini, Amalia Penna, Alessandra Orlandini, Esther Lukasiewicz, Jean–Michel Pawlotsky, Stefan Zeuzem, Solko W. Schalm, Michael von Wagner, Georgios Germanidis, Yoav Lurie, Juan I. Esteban, Bart L. Haagmans, Christophe Hezode, Martin Lagging, Francesco Negro, Yonit Homburger, Avidan U. Neumann, Carlo Ferrari, Gabriele Missale, HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology. ,vol. 133, pp. 1132- 1143 ,(2007) , 10.1053/J.GASTRO.2007.06.059

Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Yusuke Kawamura, Masahiro Kobayashi, Tetsuya Hosaka, Hitomi Sezaki, Hiromi Yatsuji, Mariko Kobayashi, Kenji Ikeda, Hiromitsu Kumada, None, Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Internal Medicine. ,vol. 46, pp. 1827- 1832 ,(2007) , 10.2169/INTERNALMEDICINE.46.0289

Javier Salmerón, Jorge Casado, Paloma Muñoz de Rueda, Victor Lafuente, Moises Diago, Manuel Romero-Gómez, Ángel Palacios, Josefa León, Ana Gila, Rosa Quiles, Luis Rodriguez, Angeles Ruiz-Extremera, Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon-ribavirin. Journal of Clinical Virology. ,vol. 41, pp. 264- 269 ,(2008) , 10.1016/J.JCV.2007.11.023

Sachin S. Kunde, Audrey J. Lazenby, Ronald H. Clements, Gary A. Abrams, Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology. ,vol. 42, pp. 650- 656 ,(2005) , 10.1002/HEP.20818

Albert Lecube, Cristina Hernández, Rafael Simó, Juan Ignacio Esteban, Joan Genescà, Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. The American Journal of Gastroenterology. ,vol. 102, pp. 2189- 2195 ,(2007) , 10.1111/J.1572-0241.2007.01402.X

D. Ferraro, M. Giglio, C. Bonura, V. Di Marco, M. U. Mondelli, A. Craxì, R. Di Stefano, Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay Journal of Viral Hepatitis. ,vol. 15, pp. 66- 70 ,(2007) , 10.1111/J.1365-2893.2007.00896.X

C. T. Ferreira, S. M. G. Vieira, C. O. Kieling, T. R. Silveira, Hepatitis A acute liver failure: follow-up of paediatric patients in southern Brazil. Journal of Viral Hepatitis. ,vol. 15, pp. 66- 68 ,(2008) , 10.1111/J.1365-2893.2008.01033.X